NCT00797849

Brief Summary

The primary purpose of this study is to determine if the group using Farabloc shows a greater reduction in pain levels than the group not using Farabloc at 6-week, 12-week and 1-month post treatment follow-ups.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
57

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2008

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2008

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

November 24, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 25, 2008

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2011

Completed
Last Updated

March 14, 2012

Status Verified

March 1, 2012

Enrollment Period

3 years

First QC Date

November 24, 2008

Last Update Submit

March 12, 2012

Conditions

Keywords

phantom limb painamputeesFarablocPhantom limb pain in the missing limb of Veteran amputees

Outcome Measures

Primary Outcomes (1)

  • The primary outcome will be pain as measured by the Numerical Pain Rating Scale (NPRS).

    Measurements will be obtained at baseline, and 6-week and 12-week follow-ups

Secondary Outcomes (2)

  • A secondary outcome will measure health-related quality of life using the 36-item Sort Form Health Survey (SF-36).

    The assessment will be conducted at pretest, 6-week, 12-week and 1-month post treatment.

  • Measurement of health care utilization will be conducted by comparing the numbers of outpatient visits emergency room visits and inpatient hospitalizations using the VA electronic medical system CPRS.

    At 12-week pretreatment and 12-week follow-up.

Study Arms (2)

1

ACTIVE COMPARATOR

Wear prosthetics laminated with Farabloc surrounding the liner. If not wearing prosthetics, subject needs to wear Farabloc sock or glove over shrinker.

Device: Farabloc Limb Cover

2

SHAM COMPARATOR

Wear prosthetics laminated with sham material surrounding the liner. If not wearing prosthetics, subject needs to wear sock or glove over shrinker.

Device: Sham Limb Cover

Interventions

Wear prosthetics, sock or glove laminated with Farabloc

Also known as: FARABLOC - LC
1

Wear prosthetics, sock or glove laminated with sham material

2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Upper or lower extremity amputees with healed stumps
  • Experience episodes or intermittent PLP
  • At least 3 episodes of PLP during the previous 6 weeks
  • Have not used Farabloc within the last 6 months

You may not qualify if:

  • Pregnant women are excluded from the study
  • Stump complications (e.g., cellulites and stump pain caused by new bone spur within the past 12 months
  • Previous use of Farabloc within 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Long Beach Healthcare System

Long Beach, California, 90822-5201, United States

Location

Related Publications (25)

  • Adams PF, Hendershot GE, Marano MA; Centers for Disease Control and Prevention/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10. 1999 Oct;(200):1-203.

    PMID: 15782448BACKGROUND
  • Ephraim PL, Dillingham TR, Sector M, Pezzin LE, Mackenzie EJ. Epidemiology of limb loss and congenital limb deficiency: a review of the literature. Arch Phys Med Rehabil. 2003 May;84(5):747-61. doi: 10.1016/s0003-9993(02)04932-8.

    PMID: 12736892BACKGROUND
  • Potter BK, Scoville CR. Amputation is not isolated: an overview of the US Army Amputee Patient Care Program and associated amputee injuries. J Am Acad Orthop Surg. 2006;14(10 Spec No.):S188-90. doi: 10.5435/00124635-200600001-00041.

    PMID: 17003197BACKGROUND
  • Lin DL, Kirk KL, Murphy KP, McHale KA, Doukas WC. Evaluation of orthopaedic injuries in Operation Enduring Freedom. J Orthop Trauma. 2004 May-Jun;18(5):300-5. doi: 10.1097/00005131-200405000-00006.

    PMID: 15105752BACKGROUND
  • Islinger RB, Kuklo TR, McHale KA. A review of orthopedic injuries in three recent U.S. military conflicts. Mil Med. 2000 Jun;165(6):463-5.

    PMID: 10870364BACKGROUND
  • Korver AJ. Amputees in a hospital of the International Committee of the Red Cross. Injury. 1993 Oct;24(9):607-9. doi: 10.1016/0020-1383(93)90124-o.

    PMID: 8288381BACKGROUND
  • Sherman RA. Phantom limb pain. Mechanism-based management. Clin Podiatr Med Surg. 1994 Jan;11(1):85-106.

    PMID: 8124659BACKGROUND
  • Ephraim PL, Wegener ST, MacKenzie EJ, Dillingham TR, Pezzin LE. Phantom pain, residual limb pain, and back pain in amputees: results of a national survey. Arch Phys Med Rehabil. 2005 Oct;86(10):1910-9. doi: 10.1016/j.apmr.2005.03.031.

    PMID: 16213230BACKGROUND
  • Kooijman CM, Dijkstra PU, Geertzen JHB, Elzinga A, van der Schans CP. Phantom pain and phantom sensations in upper limb amputees: an epidemiological study. Pain. 2000 Jul;87(1):33-41. doi: 10.1016/S0304-3959(00)00264-5.

    PMID: 10863043BACKGROUND
  • Dijkstra PU, Geertzen JH, Stewart R, van der Schans CP. Phantom pain and risk factors: a multivariate analysis. J Pain Symptom Manage. 2002 Dec;24(6):578-85. doi: 10.1016/s0885-3924(02)00538-9.

    PMID: 12551807BACKGROUND
  • Richardson C, Glenn S, Nurmikko T, Horgan M. Incidence of phantom phenomena including phantom limb pain 6 months after major lower limb amputation in patients with peripheral vascular disease. Clin J Pain. 2006 May;22(4):353-8. doi: 10.1097/01.ajp.0000177793.01415.bd.

    PMID: 16691088BACKGROUND
  • Whyte A, Niven CA. The illusive phantom: does primary care meet patient need following limb loss? Disabil Rehabil. 2004 Jul 22-Aug 5;26(14-15):894-900. doi: 10.1080/09638280410001708904.

    PMID: 15497918BACKGROUND
  • Sherman RA, Sherman CJ, Parker L. Chronic phantom and stump pain among American veterans: results of a survey. Pain. 1984 Jan;18(1):83-95. doi: 10.1016/0304-3959(84)90128-3.

    PMID: 6709380BACKGROUND
  • Wartan SW, Hamann W, Wedley JR, McColl I. Phantom pain and sensation among British veteran amputees. Br J Anaesth. 1997 Jun;78(6):652-9. doi: 10.1093/bja/78.6.652.

    PMID: 9215014BACKGROUND
  • Amir R, Devor M. Ongoing activity in neuroma afferents bearing retrograde sprouts. Brain Res. 1993 Dec 10;630(1-2):283-8. doi: 10.1016/0006-8993(93)90667-c.

    PMID: 8118694BACKGROUND
  • Jain N, Florence SL, Kaas JH. Reorganization of Somatosensory Cortex After Nerve and Spinal Cord Injury. News Physiol Sci. 1998 Jun;13:143-149. doi: 10.1152/physiologyonline.1998.13.3.143.

    PMID: 11390778BACKGROUND
  • Flor H, Elbert T, Muhlnickel W, Pantev C, Wienbruch C, Taub E. Cortical reorganization and phantom phenomena in congenital and traumatic upper-extremity amputees. Exp Brain Res. 1998 Mar;119(2):205-12. doi: 10.1007/s002210050334.

    PMID: 9535570BACKGROUND
  • Chabal C, Jacobson L, Russell LC, Burchiel KJ. Pain responses to perineuromal injection of normal saline, gallamine, and lidocaine in humans. Pain. 1989 Mar;36(3):321-325. doi: 10.1016/0304-3959(89)90091-2.

    PMID: 2710561BACKGROUND
  • Parkes CM. Factors determining the persistence of phantom pain in the amputee. J Psychosom Res. 1973 Mar;17(2):97-108. doi: 10.1016/0022-3999(73)90010-x. No abstract available.

    PMID: 4741689BACKGROUND
  • Shukla GD, Sahu SC, Tripathi RP, Gupta DK. Phantom limb: a phenomenological study. Br J Psychiatry. 1982 Jul;141:54-8. doi: 10.1192/bjp.141.1.54.

    PMID: 7116073BACKGROUND
  • Jensen MP, Turner JA, Romano JM. What is the maximum number of levels needed in pain intensity measurement? Pain. 1994 Sep;58(3):387-392. doi: 10.1016/0304-3959(94)90133-3.

    PMID: 7838588BACKGROUND
  • Jensen MP, Turner JA, Romano JM, Fisher LD. Comparative reliability and validity of chronic pain intensity measures. Pain. 1999 Nov;83(2):157-62. doi: 10.1016/s0304-3959(99)00101-3.

    PMID: 10534586BACKGROUND
  • McHorney CA, Ware JE Jr, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994 Jan;32(1):40-66. doi: 10.1097/00005650-199401000-00004.

    PMID: 8277801BACKGROUND
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473-83.

    PMID: 1593914BACKGROUND
  • Kazis LE, Ren XS, Lee A, Skinner K, Rogers W, Clark J, Miller DR. Health status in VA patients: results from the Veterans Health Study. Am J Med Qual. 1999 Jan-Feb;14(1):28-38. doi: 10.1177/106286069901400105.

    PMID: 10446661BACKGROUND

Related Links

MeSH Terms

Conditions

Phantom Limb

Condition Hierarchy (Ancestors)

Perceptual DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesPain, PostoperativePostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsSigns and SymptomsPain

Study Officials

  • An-Fu Hsiao, M.D., Ph.D.

    VA Long Beach Healthcare System

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

November 24, 2008

First Posted

November 25, 2008

Study Start

November 1, 2008

Primary Completion

November 1, 2011

Study Completion

November 1, 2011

Last Updated

March 14, 2012

Record last verified: 2012-03

Locations